Competing Actions of Type 1 Angiotensin II Receptors Expressed on T Lymphocytes and Kidney Epithelium during Cisplatin-Induced AKI
Open Access
- 7 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 27 (8) , 2257-2264
Abstract
Inappropriate activation of the renin-angiotensin system (RAS) contributes to many CKDs. However, the role of the RAS in modulating AKI requires elucidation, particularly because stimulating type 1 angiotensin II (AT1) receptors in the kidney or circulating inflammatory cells can have opposing effects on the generation of inflammatory mediators that underpin the pathogenesis of AKI. For example, TNF-α is a fundamental driver of cisplatin nephrotoxicity, and generation of TNF-α is suppressed or enhanced by AT1 receptor signaling in T lymphocytes or the distal nephron, respectively. In this study, cell tracking experiments with CD4-Cre mT/mG reporter mice revealed robust infiltration of T lymphocytes into the kidney after cisplatin injection. Notably, knockout of AT1 receptors on T lymphocytes exacerbated the severity of cisplatin-induced AKI and enhanced the cisplatin-induced increase in TNF-α levels locally within the kidney and in the systemic circulation. In contrast, knockout of AT1 receptors on kidney epithelial cells ameliorated the severity of AKI and suppressed local and systemic TNF-α production induced by cisplatin. Finally, disrupting TNF-α production specifically within the renal tubular epithelium attenuated the AKI and the increase in circulating TNF-α levels induced by cisplatin. These results illustrate discrepant tissue–specific effects of RAS stimulation on cisplatin nephrotoxicity and raise the concern that inflammatory mediators produced by renal parenchymal cells may influence the function of remote organs by altering systemic cytokine levels. Our findings suggest selective inhibition of AT1 receptors within the nephron as a promising intervention for protecting patients from cisplatin-induced nephrotoxicity.Keywords
This publication has 36 references indexed in Scilit:
- Onco-NephrologyClinical Journal of the American Society of Nephrology, 2012
- A Novel Role for Type 1 Angiotensin Receptors on T Lymphocytes to Limit Target Organ Damage in HypertensionCirculation Research, 2012
- AT 1A Angiotensin Receptors in the Renal Proximal Tubule Regulate Blood PressureCell Metabolism, 2011
- Telmisartan, a dual ARB/partial PPAR‐ γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetesDiabetes, Obesity and Metabolism, 2011
- A Role for Angiotensin II Type 1 Receptors on Bone Marrow-Derived Cells in the Pathogenesis of Angiotensin II–Dependent HypertensionHypertension, 2010
- Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cellsJournal of Clinical Investigation, 2008
- Role of Angiotensin II on Dihydrofolate Reductase, GTP-Cyclohydrolase 1 and Nitric Oxide Synthase Expressions in Renal Ischemia-ReperfusionAmerican Journal of Nephrology, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Distinct and Nonredundant In Vivo Functions of TNF Produced by T Cells and Macrophages/NeutrophilsImmunity, 2005
- NF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in RatsHypertension, 2000